Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

v3.20.2
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Series C Preferred Stock [Member]
Series E Preferred Stock [Member]
Series F Preferred Stock [Member]
Series B Preferred Stock [Member]
Series C Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Stock Divided Distributable [Member]
Accumulated Deficit [Member]
Total
Balance, beginning at Mar. 31, 2018       $ 409 $ 1   $ 141,429,941 $ 2,467,910 $ (170,861,622) $ (26,963,361)
Balance, beginning (in shares) at Mar. 31, 2018       408,508 1,132 184        
Common Shares issued for:                    
Conversion of Series B to Common       $ (365)     365      
Conversion of Series B to Common (in shares)       (364,508)   3        
Conversion of Series C Preferred Stock           $ 4 (4)      
Conversion of Series C Preferred Stock (in shares)         (404) 3,794        
Rounding Adjustment for Split (in shares)           22        
Payment of Series B Dividend             2,782 (2,782)    
Share-Based Compensation             343,730     343,730
Conversion of Debenture           $ 9 917,095     917,104
Conversion of Debenture (in shares)           9,414        
Issuance of Common Shares for Consulting Fees             234,430     234,430
Issuance of Common Shares for Consulting Fees (in shares)           14        
Warrants - Abeyance (in shares)           10        
Issuance of Series C Preferred Shares for Cash Proceeds         $ 1   14,999,999     15,000,000
Issuance of Series C Preferred Shares for Cash Proceeds (in shares)         1,577          
Stock Dividends to be Issued             (5,676,715) (5,676,715)    
Net Income (Loss)                 16,643,153 16,643,153
Balance, end at Mar. 31, 2019       $ 44 $ 2 $ 13 151,251,623 8,141,843 (154,218,469) 6,175,056
Balance, end (in shares) at Mar. 31, 2019       44,000 2,305 13,441        
Cash Paid for Settlement of Series B Preferred Stock Warrants             (25,000)     (25,000)
Common Shares issued for:                    
Conversion of Series B to Common       $ (44)     44      
Conversion of Series B to Common (in shares)       (44,000)            
Conversion of Series C Preferred Stock           $ 4,899 (4,899)      
Conversion of Series C Preferred Stock (in shares)         (11) 4,899,442        
Conversion of Debenture - Abeyance           $ 29 (29)      
Conversion of Debenture - Abeyance (in shares)           29,073        
Rounding Adjustment for Split           $ 58 (58)      
Rounding Adjustment for Split (in shares)           57,363        
Payment of Series B Dividend             3 (3)    
Payment for Consulting Fees           $ 1 331,029     331,030
Payment for Consulting Fees (in shares)           680        
Issuance of Series E and F Preferred Stock   $ 18,701,000 $ 1,417,000              
Issuance of Series E and F Preferred Stock (in shares)   1,000,000 16,750              
Change in valuation of Series E and F Preferred Stock   $ (4,035,000) $ 1,017,000              
Redemption of Series E and F Preferred Stock   $ (14,666,000) $ (2,434,000)              
Redemption of Series E and F Preferred Stock (in shares)   (1,000,000) (16,750)              
Issuance of Series C Preferred Shares for Cash Proceeds $ 5,000,000                  
Issuance of Series C Preferred Shares for Cash Proceeds (in shares) 525                  
Stock Dividends to be Issued             (7,737,086) 7,737,086    
Net Income (Loss)                 (3,856,299) (3,856,299)
Balance, end at Mar. 31, 2020 $ 5,000,000       $ 2 $ 5,000 $ 144,815,627 $ 15,878,926 $ (158,074,768) $ 2,624,787
Balance, end (in shares) at Mar. 31, 2020 525       2,294 5,000,000